Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Fahad AlKherayf

Fahad AlKherayf

University of Ottawa, Canada

Sybille Krauss

Sybille Krauss

Deutsches Zentrum für Neurodegenerative Erkrankungen, Germany

Marina Zueva

Marina Zueva

Moscow Helmholtz Research Institute of Eye Diseases, Russia

Hamed Benghuzzi

Hamed Benghuzzi

University of Mississippi Medical Center USA

David Rowell

David Rowell

Queensland Brain Institute, Australia

Ahmed Ammar

Ahmed Ammar

Dammam University, Saudi Arabia

Hui-Chieh Lee

Hui-Chieh Lee

Kaohsiung Armed Forces General Hospital, Taiwan

Giovanni Antioco Putzu

Giovanni Antioco Putzu

Casa di Cura Sant’Elena, Quartu Sant’Elena, Italy

Parkinsons Congress 2018

Session&Tracks

On behalf of the Conference Organizing Committee, it is glad that we welcome you to the official website of 4th world Congress on Parkinsons & Huntingtons Disease during August 29-30, 2018 at Zurich, Switzerland.

Parkinsons Congress 2018 has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Committee

The present Parkinsons Congress focuses on Neuromuscular Disorders occurs due to loss of communication between neurons in the brain. These disorders are noted as the greatest threat to humans in present generations around globe. More than Hundred diseases are in association with nervous system including Parkinson's disease they are Alzheimer's disease, brain tumors, Multiple Sclerosis Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Stroke and Epilepsy.

Session on: Parkinson Disease

Parkinson’s disease (PD) is a chronic and progressive disease of nervous system that possess symptoms which continue and become worse over time. It is the second commonest neurodegenerative disease after Alzheimer's disease, and in the UK, has a lifetime prevalence of between 0.1 and 0.3% of the population. The basic reason behind this condition is malfunction and death of vital nerve cells in brain. In normal conditions nerve cells present in the brain produces a neuro transmitter called dopamine that is responsible for signalling movement, emotions and co-ordination but in the case of diseased individual dopamine production slows down, hence the individual become unable to control the movement normally. There is no cure but treatment involves medication and surgery. Slowness of voluntary movements, reduced facial appearance, repetitious tongue, and diminished eye flashing, A shuffling gait with deprived arm swing and curved posture, Shaky stability; difficulty rising from a sitting position, Swallowing problems in later stages.

Related Parkinsons Conference | Parkinson congress | Parkinsons Disease Conference | Parkinsonism congress | Parkinson’s disease conference

3rd International Conference on Central Nervous System Disorders & Therapeutics Oct 02-03, 2017 Vienna, Austria, 5th International Conference on Brain Disorders and Therapeutics Nov 29-30, 2017 Madrid, Spain, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry August 27-28,2018 Tokyo, Japan, 2nd International Conference on Spine and Spinal Disorders 24–26 July 2017,Rome, Italy, 11thInternational Conference on Alzheimer’s Disease & Dementia March 29-31, 2018, Vienna, Austria, 25th Global Meeting on Neurology & Neuroscience June 14-16 Dublin, Ireland, 3rd International Conference on Neuro-Oncology and Brain Tumor April 19-20, 2018 Dubai, UAE, 40th International Conference on Psychiatric-Mental Health Nursing September 25-26,2018 Atlanta, USA, Conference on Alzheimer’s Association 16–20 July 2017,London,Uk, 22nd International Conference on Neurology & Neurophysiology April 23-25, 2018 Rome, Italy, 4th International Conference on Neurological Disorders & Stroke April 19-20, 2018 Dubai, UAE, 14th International Symposium on Neural Transplantation and Repair, Douglas, Australia, 8th International Conference on Addictive Disorders and Alcoholism May 17-18, 2018 Singapore.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk,

Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on:  Epidemiology of Parkinsons

Parkinsons disease is a neurodegenerative disorder and the cause of it remained a mystery to the scientific community. Researchers says by exposing to harmful chemicals and Pesticides mutations occurs in the genes and results in neurological disorders. With age, the condition of disease increases exponentially and men are in higher proportion to prone compared to women. On an average 10million individuals are found to be suffering from Parkinson’s disease, from where only four percent of people with Parkinson’s disease are diagnosed before the age of 50. An estimated of 40% to 60% of Parkinson disease patients suffering from depression. United States stands in the fourth position in considering the death of people due to Parkinson’s disease.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

4th Global Experts Meeting on Parkinson’s & Movement Disorders May 17-18, 2018 Singapore, Conference on Frontiers of Serotonin Beyond the Brain Nov 12-15,2017 Utah, International Conference on Nervous System and Nerve Diseases September 17-18, 2018 Philadelphia , USA, 4th World Congress on Epilepsy and Treatment September 17-18, 2018 Bali, Indonesia, Conference on Amyotrophic Lateral Sclerosis (ALS) & Related Motor Neuron Diseases 23–28 July 2017, Stowe, US,  12th World Congress on Advances and Innovations in Dementia Sep 17-18, 2018, Singapore, 3rd International Conference on Spine and Spinal Disorder November 5-6, 2018 San Francisco, USA, 7th International Conference on Neurological Disorders and Stroke September 10-12, 2018 Dublin, Ireland, 25th European Neurology Congress Aug 06-08,2018 Madrid, Spain, 3rd International conference on Neuroradiology & Imaging May 30-31, 2018 Osaka, Japan.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

 

Session on:  Neuromuscular Disorders

Neurons are the specialized cells that are responsible for communication, when they cannot produce signals communication between nervous system breaks and results in neuromuscular disorders. Most of these disorders are thought be inheritable and treatment is given to improve the life of patient and no cure is available to completely eradicate the condition.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Huntington Disease

Huntington’s disease is inherited from Parents and often symptoms will be more like Parkinson’s disease which include problem with mood, mental abilities, Swallowing, Speaking, Sleep Disturbances followed by loss of co-ordination and unsteady gait. A gene called HTT(Huntingtin) which is responsible for coding protein Huntingtin, if any mutation to that gene it will cause disturbances in the brain and results in death of brain cell and leads to Huntington’s disease. Abnormalities with the mutant huntingtin include Cardiac Failure, Weight Loss, Osteoporosis, reduced glucose level. This condition is normally observed in the individuals under the age of fifties.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

3rd International Conference on Central Nervous System Disorders & Therapeutics Oct 02-03, 2017 Vienna, Austria, 5th International Conference on Brain Disorders and Therapeutics Nov 29-30, 2017 Madrid, Spain, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry August 27-28,2018 Tokyo, Japan, 2nd International Conference on Spine and Spinal Disorders 24–26 July 2017,Rome, Italy, 11thInternational Conference on Alzheimer’s Disease & Dementia March 29-31, 2018, Vienna, Austria, 25th Global Meeting on Neurology & Neuroscience June 14-16 Dublin, Ireland, 3rd International Conference on Neuro-Oncology and Brain Tumor April 19-20, 2018 Dubai, UAE, 40th International Conference on Psychiatric-Mental Health Nursing September 25-26,2018 Atlanta, USA, Conference on Alzheimer’s Association 16–20 July 2017,London,Uk, 22nd International Conference on Neurology & Neurophysiology April 23-25, 2018 Rome, Italy, 4th International Conference on Neurological Disorders & Stroke April 19-20, 2018 Dubai, UAE, 14th International Symposium on Neural Transplantation and Repair, Douglas, Australia, 8th International Conference on Addictive Disorders and Alcoholism May 17-18, 2018 Singapore.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

 

Session on: Risk Factors of Parkinson’s disease

Symptoms and progression of disease will not be similar among the suffering individuals but people with Parkinson’s are at higher rate of developing related risks. Developing these conditions is not a certainty, only a possibility. Knowing the conditions can help a person with Parkinson’s disease or associated symptoms and helps to take preventative measures for a better life. Parkinsons disease have a chance of creating mental ailment which can be mild or serious. It includes cognition (early stage symptoms), mood, behaviour which are considered as major impairment when compared to normal populational. The common mood alterations seen in the patients are despair, eagerness, indifference.

Related Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neuromuscular Conference

4th Global Experts Meeting on Parkinson’s & Movement Disorders May 17-18, 2018 Singapore, Conference on Frontiers of Serotonin Beyond the Brain Nov 12-15,2017 Utah, International Conference on Nervous System and Nerve Diseases September 17-18, 2018 Philadelphia , USA, 4th World Congress on Epilepsy and Treatment September 17-18, 2018 Bali, Indonesia, Conference on Amyotrophic Lateral Sclerosis (ALS) & Related Motor Neuron Diseases 23–28 July 2017, Stowe, US,  12th World Congress on Advances and Innovations in Dementia Sep 17-18, 2018, Singapore, 3rd International Conference on Spine and Spinal Disorder November 5-6, 2018 San Francisco, USA, 7th International Conference on Neurological Disorders and Stroke September 10-12, 2018 Dublin, Ireland, 25th European Neurology Congress Aug 06-08,2018 Madrid, Spain, 3rd International conference on Neuroradiology & Imaging May 30-31, 2018 Osaka, Japan.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Pathophysiology and Pharmacology

Parkinson’s disease is originated because of the gradual loss of cells in the substantia nigra of the brain. Dopamine is a neurotransmitter that transmits signals between two regions of the brain to coordinate activities like movement of limbs. If there is deficiency in dopamine production results in loss of co-ordination and end up with symptoms of Parkinson’s Disease. As the disease progresses, nervous system and brain degenerates causing a higher movement disorder.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society

 

Session on: Diagnosis for Parkinson’s disease

Early stage identification of Parkinson’s disease is difficult but includes some imaging studies. MRI (magnetic resonance imaging) and CT (computer tomogram) are used by many physicians to find out other relating Parkinson’s diseases such as encephalitis, Tumours, Hydrocephalus. Level of dopamine release and activity of brain can easily detect using PET and SPECT examining.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

3rd International Conference on Central Nervous System Disorders & Therapeutics Oct 02-03, 2017 Vienna, Austria, 5th International Conference on Brain Disorders and Therapeutics Nov 29-30, 2017 Madrid, Spain, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry August 27-28,2018 Tokyo, Japan, 2nd International Conference on Spine and Spinal Disorders 24–26 July 2017,Rome, Italy, 11thInternational Conference on Alzheimer’s Disease & Dementia March 29-31, 2018, Vienna, Austria, 25th Global Meeting on Neurology & Neuroscience June 14-16 Dublin, Ireland, 3rd International Conference on Neuro-Oncology and Brain Tumor April 19-20, 2018 Dubai, UAE, 40th International Conference on Psychiatric-Mental Health Nursing September 25-26,2018 Atlanta, USA, Conference on Alzheimer’s Association 16–20 July 2017,London,Uk, 22nd International Conference on Neurology & Neurophysiology April 23-25, 2018 Rome, Italy, 4th International Conference on Neurological Disorders & Stroke April 19-20, 2018 Dubai, UAE, 14th International Symposium on Neural Transplantation and Repair, Douglas, Australia, 8th International Conference on Addictive Disorders and Alcoholism May 17-18, 2018 Singapore.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Parkinson’s disease: Complications

Parkinson's disease is usually accompanied by additional problems, which may be cured and they       are thinking difficulties, swallowing problems, depression and emotional changes, sleep difficulties, constipation, blood pressure changes, fatigue, pain.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

4th Global Experts Meeting on Parkinson’s & Movement Disorders May 17-18, 2018 Singapore, Conference on Frontiers of Serotonin Beyond the Brain Nov 12-15,2017 Utah, International Conference on Nervous System and Nerve Diseases September 17-18, 2018 Philadelphia , USA, 4th World Congress on Epilepsy and Treatment September 17-18, 2018 Bali, Indonesia, Conference on Amyotrophic Lateral Sclerosis (ALS) & Related Motor Neuron Diseases 23–28 July 2017, Stowe, US,  12th World Congress on Advances and Innovations in Dementia Sep 17-18, 2018, Singapore, 3rd International Conference on Spine and Spinal Disorder November 5-6, 2018 San Francisco, USA, 7th International Conference on Neurological Disorders and Stroke September 10-12, 2018 Dublin, Ireland, 25th European Neurology Congress Aug 06-08,2018 Madrid, Spain, 3rd International conference on Neuroradiology & Imaging May 30-31, 2018 Osaka, Japan.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Mitochondrial Dysfunction

The known cause of Parkinson’s disease is reduced level of dopamine production by neurons in the brain but surprisingly the main cause was malfunctioning of cell organelles like mitochondria leads to increased oxidative stress which in turn results in cell death and finally ends with Parkinsons disease with motor and non-motor symptoms. The reason may be both genetic and environment factors.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Insights and therapeutics: Parkinson’s disease

No cure has been identified to Parkinson’s disease, but use of drugs can slow down the progression. Normally prescribed by physicians include change of life style, regular aerobic exercise and prescribed therapeutic supplement. It is noted that people will have beneficial effect who are taking co-enzyme Q10 during their initial stage of disease. It is unclear how genetical changes cause Parkinson disease or influence the risk of developing the disorder. Some gene mutations(alterations) such as LRRK 2, PARK 7, PINK 1, PRKN disturb the cell mechanism that breaks down undesired proteins in neurons which are responsible for dopamine production. Hence, undegraded proteins accumulate, resulting in death of vital nerve cells and subsequently lowers the level of dopamine production. In most cases of Parkinson disease, protein deposits called Lewy bodies. It is unclear whether Lewy bodies play a key role in killing nerve cells or just part of the cells which are responsible to the disease. Yoga, massage, acupuncture, meditation, music or art therapy, alexander technique is also regarding as best methods to control neurological disorders particularly Parkinson’s disease, Alzheimer’s and neuropsychiatric. Tetrabenazine, neuroleptics, mirtazapine can be taken to for treating chorea.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

3rd International Conference on Central Nervous System Disorders & Therapeutics Oct 02-03, 2017 Vienna, Austria, 5th International Conference on Brain Disorders and Therapeutics Nov 29-30, 2017 Madrid, Spain, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry August 27-28,2018 Tokyo, Japan, 2nd International Conference on Spine and Spinal Disorders 24–26 July 2017,Rome, Italy, 11thInternational Conference on Alzheimer’s Disease & Dementia March 29-31, 2018, Vienna, Austria, 25th Global Meeting on Neurology & Neuroscience June 14-16 Dublin, Ireland, 3rd International Conference on Neuro-Oncology and Brain Tumor April 19-20, 2018 Dubai, UAE, 40th International Conference on Psychiatric-Mental Health Nursing September 25-26,2018 Atlanta, USA, Conference on Alzheimer’s Association 16–20 July 2017,London,Uk, 22nd International Conference on Neurology & Neurophysiology April 23-25, 2018 Rome, Italy, 4th International Conference on Neurological Disorders & Stroke April 19-20, 2018 Dubai, UAE, 14th International Symposium on Neural Transplantation and Repair, Douglas, Australia, 8th International Conference on Addictive Disorders and Alcoholism May 17-18, 2018 Singapore.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Managing life with Parkinson’s disease

Since the symptoms and progression of disease are not similar among individuals early stage detection can help to reduce the worseness. Treatment and complete abolition is not known to research groups but maintaining the instructions and following the medication prescribed by physician can better the life. Individual should get practised to maintain the stress levels and depression by daily communicating with close relatives, friends. Patients can improve the life by following guidelines given by counsellor.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

4th Global Experts Meeting on Parkinson’s & Movement Disorders May 17-18, 2018 Singapore, Conference on Frontiers of Serotonin Beyond the Brain Nov 12-15,2017 Utah, International Conference on Nervous System and Nerve Diseases September 17-18, 2018 Philadelphia , USA, 4th World Congress on Epilepsy and Treatment September 17-18, 2018 Bali, Indonesia, Conference on Amyotrophic Lateral Sclerosis (ALS) & Related Motor Neuron Diseases 23–28 July 2017, Stowe, US,  12th World Congress on Advances and Innovations in Dementia Sep 17-18, 2018, Singapore, 3rd International Conference on Spine and Spinal Disorder November 5-6, 2018 San Francisco, USA, 7th International Conference on Neurological Disorders and Stroke September 10-12, 2018 Dublin, Ireland, 25th European Neurology Congress Aug 06-08,2018 Madrid, Spain, 3rd International conference on Neuroradiology & Imaging May 30-31, 2018 Osaka, Japan.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

Session on: Neurosurgery

Presently Deep brain stimulation is widely recommended for improving people suffering with Parkinson’s disease one is deep brain stimulation (DBS) and is performed by inserting a tube in the small intestine and is used to treat a variety of deactivating neurological symptoms most commonly the draining symptoms of Parkinson’s disease (PD), such as tremor, rigidity, stiffness, slowed movement, and walking problems. There will be no effect with using DBS to healthy brain tissue by terminating nerve cells. Instead the procedure blocks electrical signals from targeted areas in the brain.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Free Radicles and Aging in Parkinsons

Free radicles have both beneficial and baleful effect to human body. These are produced with in the body by metabolism and enters body through external sources such as pollution, radiation, therapeutics etc; Oxidative stress is known to cause many neurological diseases such as Alzheimer’s, Parkinson’s disease, Amyotrophic lateral sclerosis(ALS). With oldness, there is a typical failure of the dopamine producing neurons. Out of surprise 2% of the 1 million people with the disease are thought to be below the age of fifty. In some of the rare situations symptoms are seen in children and teens and it is known as juvenile parkinsonism.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

3rd International Conference on Central Nervous System Disorders & Therapeutics Oct 02-03, 2017 Vienna, Austria, 5th International Conference on Brain Disorders and Therapeutics Nov 29-30, 2017 Madrid, Spain, 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry August 27-28,2018 Tokyo, Japan, 2nd International Conference on Spine and Spinal Disorders 24–26 July 2017,Rome, Italy, 11thInternational Conference on Alzheimer’s Disease & Dementia March 29-31, 2018, Vienna, Austria, 25th Global Meeting on Neurology & Neuroscience June 14-16 Dublin, Ireland, 3rd International Conference on Neuro-Oncology and Brain Tumor April 19-20, 2018 Dubai, UAE, 40th International Conference on Psychiatric-Mental Health Nursing September 25-26,2018 Atlanta, USA, Conference on Alzheimer’s Association 16–20 July 2017,London,Uk, 22nd International Conference on Neurology & Neurophysiology April 23-25, 2018 Rome, Italy, 4th International Conference on Neurological Disorders & Stroke April 19-20, 2018 Dubai, UAE, 14th International Symposium on Neural Transplantation and Repair, Douglas, Australia, 8th International Conference on Addictive Disorders and Alcoholism May 17-18, 2018 Singapore.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Novel Therapeutics

The commonly used drug to treat Parkinson’s disease is Levodopa which has higher frequency to develop motor Fluctuations and results in L-dopa-induced dyskinesia (LID). Since the Characteristic key cause of Parkinson’s disease is reduced production level dopamine by neurons, research studies developed a molecule called LXR (Liver X Receptor) where it has got potential to reduce the loss of dopaminergic neurons. Researchers propose novel ideas to treat Parkinson’s disease to reduce the risk of causing side effects, frequency of dyskinesia, to treat cognitive disorders such as anxiety and depression.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

Session on: Clinical Trials in Parkinsonism

To develop a promising drug or treatment for Parkinson’s disease observational study is being conducted by scientist in laboratory to provide patients with better life. Clinical trials are performed to slowdown the progression and reduce the symptoms.

Related Parkinsons Conference | Parkinson’s congress | Parkinsons Disease Conference | Neurology Conference | Parkinsonism Congress

4th Global Experts Meeting on Parkinson’s & Movement Disorders May 17-18, 2018 Singapore, Conference on Frontiers of Serotonin Beyond the Brain Nov 12-15,2017 Utah, International Conference on Nervous System and Nerve Diseases September 17-18, 2018 Philadelphia , USA, 4th World Congress on Epilepsy and Treatment September 17-18, 2018 Bali, Indonesia, Conference on Amyotrophic Lateral Sclerosis (ALS) & Related Motor Neuron Diseases 23–28 July 2017, Stowe, US,  12th World Congress on Advances and Innovations in Dementia Sep 17-18, 2018, Singapore, 3rd International Conference on Spine and Spinal Disorder November 5-6, 2018 San Francisco, USA, 7th International Conference on Neurological Disorders and Stroke September 10-12, 2018 Dublin, Ireland, 25th European Neurology Congress Aug 06-08,2018 Madrid, Spain, 3rd International conference on Neuroradiology & Imaging May 30-31, 2018 Osaka, Japan.

Associations:

National Parkinson Foundation, European Parkinson’s Disease Association, American Parkinson Disease Association, UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, Michael J. Fox Foundation, Parkinson Association of the Carolinas, Parkinson’s NSW, Parkinson's Unity Walk, Movement Disorder Society of Japan, Austrian Parkinson's Disease Society, International Parkinson and Movement Disorder Society, Danish Movement Disorder Society.

 

About Conference


On behalf of Organizing Committee we invite all the participants from all over the world to attend the Parkinsons Congress  2018 entitled 4th World Congress on Parkinsons & Huntingtons Disease August 29-30, 2018  Zurich, Switzerland.

The present Parkinsons Congress focuses on Neurological disorders occurs due to loss of communication between neurons in the brain. These disorders are noted as the greatest threat to humans in present generations around globe. More than Hundred diseases are in association with nervous system including Parkinson's disease they are Alzheimer's disease, brain tumors, Multiple Sclerosis Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Stroke and Epilepsy.

Europeans are besieged by mental and neurological illnesses, virtually 165 million people are recorded as suffering from brain disorders annually among which only third of cases receiving the surgery or medication., it found neurological disorders involve economic status about 386 billion euros ($555 billion) per year which is difficult for growing nations to overcome. This summit provides opportunity for all the applicants, professors, research students to exchange ideas, complications and innovations with one another and can collaborate. 

At National Institute of Health funding package is of $34 billion for the economic year 2017 to improve life of patients who are suffering from Parkinson’s disease and to rise the research ideas and to reduce mental disorders around globe. PRP (Parkinson's Research Program) fund received amount of $16 million annually to research in Neuromuscular disorders such as Alzheimer’s, Parkinson’s disease, Huntington’s disease.

Omics Group Organizes many conferences around globe and gathers eminent persons with an idea of Ameliorating Human life.

Why to attend?

4th World Congress on Parkinsons & Huntington Disease Acts as a single platform to unite all Scientists, Neurosurgeons, Clinician, Industry Specialists, Neurology Experts, Scholars to discuss regarding Neurological disorders with an aim to make patients feel better with innovative research outcomes. 

Target audience:

Neurologists and Directors, Neuroscientists, Physicians, Specialists, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students from Academia in the study of Parkinson disease, Students from Academia in the research of Neurology and Neuroscience, Therapists

Market Analysis

On behalf of the Parkinsons congress 2018, it is cheerful in welcoming you all attendees, speakers, and exhibitors from all over the world to recognise recent research ideas in the field of neuroscience and related disorders to Europe international conference during 29-30, August 2018.

The main goal of this conference is to bring out ideas in treating Parkinsons disease and to improve the of life through advanced treating methods.

Reasons to undertake:

Parkinsons congress 2018 is conducted exclusively in support to worldwide neuro researchers. We endeavour to make Parkinson’s congress 2018 a grand success, with the support of high eminent talks from the neuro science and Parkinson’s disease communities. During the time, you spend at this congress, we promise you that we will provide you with world class facilities and hospitality.

On an average 10million individuals are found to be suffering from Parkinson’s disease, from where only four percent of people with Parkinson’s disease are diagnosed before the age of 50. An estimated of 40% to 60% of Parkinson disease patients suffering from depression. United States stands in the fourth position in considering the death of people due to Parkinson’s disease. Men are recorded as most prone to Parkinson’s disease compared to women.

Parkinson Disease is a neurological disorder and the reason for the cause is remined as a question for the scientific community and thought to be because of low levels of dopamine produced by the neurons in the brain. Several treatments were identified which includes physiotherapy, surgery and yoga to solve the neurological disorders and progression of disease condition among the patient assemblies. People experience with Slowness of voluntary Movements, Decreased Facial Expression, Monotonous Speech, and decreased Eye Blinking, A shuffling gait with poor arm swing and stooped posture, Unsteady balance; difficulty rising from a sitting position, Swallowing problems in later stages.

About Zurich:

This convocation will focus on the recent advances and novel ideas in each series of Parkinson’s research, and it will offer an incomparable occasion for specialists from all over the globe to meet, collaborate, and extricate with diverse scientific relations.

Zurich is the largest and capital city of Switzerland, the entire economic area is like a gradually developed, densely networked science park. The public and private research has a long-standing tradition and have its own identification to play role in the future. The economy and research work are closely together, while innumerable high-tech organisations provide additional impetus for the innovation process. The city of Zürich offers an extremely varied cultural program. Things that no one can miss at Zurich include Uetliberg Mountain, lake Zurich, Museum of art. The city is enriched with heritage and culture along with modernity and economic progress. This conference also promises you to fill with good memories at Zurich with its attractions.

Focused concepts in congress:

Parkinson’s disease

Neuroscience

Neuromuscular Disorders

Environment and genetic changes involvement in neuro transmitters

Effect of free radicles and aging in patients

Diagnosis and imaging of Parkinson’s disease

Pathophysiology and neuropsychiatry

Neurogenic Orthostatic Hypotension

Parkinson’s disease condition.

Medication and surgery for Parkinson’s disease

Major Associations around the globe:

National Parkinson Foundation

American Parkinson Disease Association (APDA)

Parkinson’s disease Foundation

Movement Disorder Society of Australia

Parkinson's Unity Walk

Movement Disorder Society of Japan

Moroccan Neurological Society Movement Disorders Group

Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia

Ecuador Movement Disorders Group

Austrian Parkinson's Disease Society

Danish Movement Disorder Society

International Parkinson and Movement Disorder Society

Parkinson’s Disease and Movement Disorders Society of India

Top universities globally working in the field of Parkinson Disease

University of Bath

The University of Queensland

University of Bristol

University of Cambridge

The Imperial College of Science and Medicine

Duke University

University of Milan

Karolinska Institute

University of Hamburg

The University of Edinburgh

University of Munich

University of Rochester

University of Zurich

Leiden University

University of Bristol

University of Helsinki

University of Freiburg

University of Frankfurt

Top universities in Switzerland:

University of Zurich

University of Basel

University of Geneva

University of Lausanne

Swiss federal institute of technology Zurich

University of Bern

Ecole ploytechinque federale of Lausanne.

 

 

 

Past Conference Report

On behalf of Organizing Committee, we take an immense pleasure in announcing the inauguration of 3rd International Conference on Parkinson’s disease and Movement Disorders-2017 during September 25-26,2017 at Chicago, USA. We have received a benevolent response around the globe for Parkinsons-2017. The conference was conducted with the theme “Research Strategies, propelled advancements and developments in Parkinson’s disease”. This conference was noticeable with the presence of eminent researchers with their novel ideas, business delegates and talented young research communities.

This conference created a platform to meet Leading World Parkinsons doctors, Neurosurgeons, Neuro radiologists, Clinicians, Deans, Care Experts, Scholars and other professionals in which many topics were discussed in depth to provide up-to-date information to the world regarding Parkinson’s disease. While, the summit ended up in providing an occasion to share concepts and practices.

The platform was decorated with peerless speakers, who enlightened the delegates with their novel research ideas and on various scientific topics related to the field of Parkinson’s disease. The eminent personalities at the conference were Jean Barclay, Manager at Global Clinical Development and Regulatory Affairs at Luye Pharma, USAGuy H. Fontaine Professor at University Pierre et Marie Curie, France, Junxia Xie, Director of Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, China, Srinivas Avathvadi Venkatesan.

We take opportunity to appreciate to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Associates and Editorial Board Members of Journal of Depression and Anxiety, Journal of Alzheimer Disease & Parkinsonism and Journal of Neurological Disorders who supported the conference in every aspect for making an enormous success.

We once again thank all the communities of research for long term support and massive positive response. This encourages us to continue organizing events and conferences for advancing the Research in helping human life. Therefore, it is glad to announce commencement of "4th World congress on Parkinsons and Huntington Disease" which will be held during August 29-30, 2018 Zurich, Switzerland.

To Collaborate Scientific Professionals around the World

Conference Date August 29-30, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Alzheimers Disease & Parkinsonism Journal of Neurological Disorders Journal of Neurology & Neurophysiology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner